Cardeon’s entire shareholding in Neola Medical acquired by major shareholders
Press communication Lund, Sweden, May 14, 2024 This is a translation of the Swedish press release published 2024-05-14 Neola Medical AB (publ) announced today that Cardeon AB’s entire 2,358,805 shares in Neola Medical have been acquired by the company’s...
Successful results in completed Human Factors Validation Study with Neola® in the USA
Press communication Lund, Sweden, April 18, 2024 This is a translation of the Swedish press release published 2024-04-18 Neola Medical AB (publ) has completed the Human Factors Validation Study with Neola®, the company’s medical device for continuous lung...
Neola® wins silver medal and 25 000 USD in Stanford Pediatric Device Consortium (PDC) Accelerator Pitch Competition 2024
Press communication Lund, Sweden, March 28, 2024 This is a translation of the Swedish press release published 2024-03-28 Neola Medical’s product for lung monitoring of preterm born infants, Neola®, was selected by Stanford as one of the top ten most promising...
Neola Medical’s CEO shares more about the latest news in the spring investor letter
Press communication Lund, Sweden, March 20, 2024 This is a translation of the Swedish press release published 2024-03-20 The initial months of 2024 continue with intensive work and positive progress for Neola Medical in preparation for upcoming studies for market...